TherapeuticsMD, Inc. operates as a women's health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space, as well as directly through its Website. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Didn't see anything either. Only news headlines I saw with a quick search was that Guggenheim reiterated their buy rating.
Just unhalted >> TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control - https://finance.yahoo.com/news/therapeuticsmd-announces-fda-approval-annovera-190500487.html
I strongly believe there will soon be a merger, acquisition or excellent strategic partnership announced soon. This current increase in stock price after a long period of time of being thinly traded, and with no significant news or announcements indicates to me that it must be insiders slowly loading up. I see $3-$4 in this stocks future near term. (within 90 days)
